Thomas E. Webb

3.4k total citations
137 papers, 2.7k citations indexed

About

Thomas E. Webb is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Thomas E. Webb has authored 137 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 13 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Thomas E. Webb's work include RNA and protein synthesis mechanisms (31 papers), RNA Research and Splicing (29 papers) and RNA modifications and cancer (16 papers). Thomas E. Webb is often cited by papers focused on RNA and protein synthesis mechanisms (31 papers), RNA Research and Splicing (29 papers) and RNA modifications and cancer (16 papers). Thomas E. Webb collaborates with scholars based in United States, Canada and United Kingdom. Thomas E. Webb's co-authors include Dorothy E. Schumm, Van R. Potter, Günter Blobel, Irwin B. Levitan, Harold P. Morris, Zbigniew Wałaszek, Janis Racevskis, B. Rose, A.H. Sehon and Donald J. McNamara and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas E. Webb

137 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Webb United States 31 1.6k 287 274 225 206 137 2.7k
L Cantoni Italy 26 1.1k 0.7× 186 0.6× 152 0.6× 228 1.0× 76 0.4× 82 2.5k
H. W. Goedde Germany 22 796 0.5× 277 1.0× 154 0.6× 121 0.5× 294 1.4× 158 2.3k
L. Golberg United States 32 646 0.4× 257 0.9× 169 0.6× 209 0.9× 139 0.7× 135 2.9k
Robert L. Saul United States 8 1.2k 0.7× 413 1.4× 114 0.4× 117 0.5× 120 0.6× 8 2.5k
Leon L. Miller United States 26 866 0.5× 418 1.5× 442 1.6× 152 0.7× 166 0.8× 76 2.5k
G Szász Germany 15 637 0.4× 186 0.6× 172 0.6× 166 0.7× 117 0.6× 42 2.3k
Santosh Nigam Germany 32 1.3k 0.8× 366 1.3× 175 0.6× 173 0.8× 102 0.5× 122 3.1k
Chi‐Sun Wang United States 23 889 0.5× 207 0.7× 149 0.5× 152 0.7× 130 0.6× 38 2.0k
Takeshi Kumagai Japan 26 1.5k 0.9× 174 0.6× 119 0.4× 208 0.9× 132 0.6× 91 3.1k
William N. Howald United States 28 1.0k 0.6× 173 0.6× 108 0.4× 269 1.2× 182 0.9× 50 2.9k

Countries citing papers authored by Thomas E. Webb

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Webb more than expected).

Fields of papers citing papers by Thomas E. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Webb. The network helps show where Thomas E. Webb may publish in the future.

Co-authorship network of co-authors of Thomas E. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Webb. A scholar is included among the top collaborators of Thomas E. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Webb. Thomas E. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webb, Thomas E., et al.. (2020). The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapy. Clinical and Translational Radiation Oncology. 24. 123–126. 5 indexed citations
2.
Mcloughlin, Benjamin C., Amy Miles, Thomas E. Webb, et al.. (2020). Functional and cognitive outcomes after COVID-19 delirium. European Geriatric Medicine. 11(5). 857–862. 113 indexed citations
3.
Miles, Amy, et al.. (2020). Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people. European Geriatric Medicine. 11(5). 851–855. 42 indexed citations
4.
Webb, Thomas E. & Keith R. Cadwallader. (2001). Aroma Components of an Oil-Based Grill Flavoring by Direct Thermal Desorption-Gas Chromatography-Olfactometry and Sample Dilution Analysis. Advances in experimental medicine and biology. 488. 143–150. 2 indexed citations
5.
Gupton, John T., et al.. (1998). Cytotoxicity of Substituted Alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 Lymphoid Leukemia Cells. Archiv der Pharmazie. 331(11). 337–341. 24 indexed citations
6.
Stromberg, Paul C., Dorothy E. Schumm, Thomas E. Webb, H. W. C. Ward, & C. Guillermo Couto. (1995). Evaluation of oncofetal protein-related mRNA transport activity as a potential early cancer marker in dogs with malignant neoplasms. American Journal of Veterinary Research. 56(12). 1559–1563. 1 indexed citations
8.
Webb, Thomas E., Paul C. Stromberg, Hussein Abou‐Issa, Robert W. Curley, & Melvin L. Moeschberger. (1992). Effect of dietary soybean and licorice on the male F344 rat: An integrated study of some parameters relevant to cancer chemoprevention. Nutrition and Cancer. 18(3). 215–230. 13 indexed citations
9.
Abou‐Issa, Hussein, et al.. (1992). Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate. European Journal of Cancer. 28(4-5). 784–788. 1 indexed citations
10.
Schumm, Dorothy E., et al.. (1991). Development and Use of Monoclonal Antibodies Against an Oncofetal Protein Associated with Carcinogenesis and Tumorigenesis. Immunological Investigations. 20(3). 269–286. 1 indexed citations
11.
Stromberg, Paul C., et al.. (1991). Expression of an oncofetal protein (OFP) in rat and human leukemia cells. Leukemia Research. 15(6). 427–433. 1 indexed citations
12.
Dwivedi, Chandradhar, et al.. (1990). Effect of calcium glucarate on β-glucuronidase activity and glucarate content of certain vegetables and fruits. Biochemical Medicine and Metabolic Biology. 43(2). 83–92. 31 indexed citations
13.
Abou‐Issa, Hussein, et al.. (1989). Synergistic interaction between 13-cis-retinoic acid and glucarate: Activity against rat mammary tumor induction and MCF-7 cells. Biochemical and Biophysical Research Communications. 163(3). 1364–1369. 13 indexed citations
14.
Schumm, Dorothy E., et al.. (1989). Hybridization analysis of RNA transported from rat liver nuclei in response to 35 kDa normal and 60 kDa messenger RNA transport factors. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1009(1). 54–60. 2 indexed citations
15.
Dwivedi, Chandradhar, et al.. (1989). Effect of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in rats. Carcinogenesis. 10(8). 1539–1541. 22 indexed citations
16.
Wałaszek, Zbigniew, et al.. (1988). Repression by sustained‐release β‐glucuronidase inhibitors of chemical carcinogen‐mediated induction of a marker oncofetal protein in rodents. Journal of Toxicology and Environmental Health. 23(1). 15–27. 7 indexed citations
17.
Wałaszek, Zbigniew, et al.. (1986). Nutritional supplement of a D-glucaro-1,4-lactone precursor inhibits 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 2 indexed citations
18.
Koestner, A., et al.. (1980). Characteristics of RNA release from rat brain nuclei and effect of neurocarcinogenesis. Biochemical and Biophysical Research Communications. 92(4). 1348–1354. 5 indexed citations
19.
Chang, Ming, Thomas E. Webb, & Adalbert Koestner. (1979). Distribution of O6-methylguanine in rat dna following pretreatment in vivo with methylnitrosourea. Cancer Letters. 6(3). 123–127. 11 indexed citations
20.
Webb, Thomas E., et al.. (1971). Temporal Changes in DNA and RNA Synthesis in the Regenerating Liver of Hydrocortisone-treated Rats. Cancer Research. 31(6). 876–881. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026